Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Biol Chem ; 276(9): 6656-65, 2001 Mar 02.
Artigo em Inglês | MEDLINE | ID: mdl-11071894

RESUMO

Using a culture model of glial tumorigenesis, we identified a novel gene that was up-regulated in malignant mouse astrocytes following the loss of p53. The gene represents the murine homologue of pescadillo, an uncharacterized gene that is essential for embryonic development in zebrafish. Pescadillo is a strongly conserved gene containing unique structural motifs such as a BRCA1 C-terminal domain, clusters of acidic amino acids and consensus motifs for post-translational modification by SUMO-1. Pescadillo displayed a distinct spatial and temporal pattern of gene expression during brain development, being detected in neural progenitor cells and postmitotic neurons. Although it is not expressed in differentiated astrocytes in vivo, the pescadillo protein is dramatically elevated in malignant human astrocytomas. Yeast strains harboring temperature-sensitive mutations in the pescadillo gene were arrested in either G(1) or G(2) when grown in nonpermissive conditions, demonstrating that pescadillo is an essential gene in yeast and is required for cell cycle progression. Consistent with the latter finding, DNA synthesis was only observed in mammalian cells expressing the pescadillo protein. These results suggest that pescadillo plays a crucial role in cell proliferation and may be necessary for oncogenic transformation and tumor progression.


Assuntos
Ciclo Celular , Regulação Neoplásica da Expressão Gênica , Neoplasias/metabolismo , Proteínas/genética , Sequência de Aminoácidos , Animais , Astrócitos/metabolismo , Astrocitoma/metabolismo , Encéfalo/metabolismo , Bromodesoxiuridina/metabolismo , Células COS , Proteínas de Ciclo Celular , Células HeLa , Humanos , Dados de Sequência Molecular , Peso Molecular , Proteínas/análise , Proteínas/fisiologia , Proteínas de Ligação a RNA
2.
J Biol Chem ; 274(32): 22569-80, 1999 Aug 06.
Artigo em Inglês | MEDLINE | ID: mdl-10428835

RESUMO

Apoptosis is a form of programmed cell death that plays a pivotal role during development and in the homeostasis of the adult nervous systems. However, mechanisms that regulate neuronal apoptosis are not well defined. Here, we report that brain-derived neurotrophic factor (BDNF) protects cortical neurons against apoptosis induced by camptothecin or serum deprivation and activates the extracellular-signal-regulated kinase (ERK) and the phosphatidylinositol 3-kinase (PI 3-kinase) pathways. Using pharmacological agents and transient transfection with dominant interfering or constitutive active components of the ERK or the PI 3-kinase pathway, we demonstrate that the ERK pathway plays a major role in BDNF neuroprotection against camptothecin. Furthermore, ERK is activated in cortical neurons during camptothecin-induced apoptosis, and inhibition of ERK increases apoptosis. In contrast, the PI 3-kinase pathway is the dominant survival mechanism for serum-dependent survival under normal culture conditions and for BDNF protection against serum withdrawal. These results suggest that the ERK pathway is one of several neuroprotective mechanisms that are activated by stress to counteract death signals in central nervous system neurons. Furthermore, the relative contribution of the ERK and PI 3-kinase pathways to neuronal survival may depend on the type of cellular injury.


Assuntos
Fator Neurotrófico Derivado do Encéfalo/farmacologia , Proteínas Quinases Dependentes de Cálcio-Calmodulina/metabolismo , Córtex Cerebral/metabolismo , Neurônios/efeitos dos fármacos , Fosfatidilinositol 3-Quinases/metabolismo , Animais , Apoptose , Proteínas Quinases Dependentes de Cálcio-Calmodulina/antagonistas & inibidores , Camptotecina/farmacologia , Células Cultivadas , Córtex Cerebral/citologia , Cromonas/farmacologia , Meios de Cultura Livres de Soro/farmacologia , Flavonoides/farmacologia , Morfolinas/farmacologia , Fármacos Neuroprotetores/farmacologia , Inibidores de Fosfoinositídeo-3 Quinase , Ratos , Ratos Sprague-Dawley , Transdução de Sinais , Inibidores da Topoisomerase I
3.
J Fla Med Assoc ; 83(5): 335-41, 1996 May.
Artigo em Inglês | MEDLINE | ID: mdl-8666972

RESUMO

Bioenergetic defects and oxidative stress may be critical links in an excitotoxic mechanism of neuronal death. Oxidative stress, a condition describing the production of oxygen radicals beyond a threshold for proper antioxidant neutralization, has been implicated as a pathologic condition in several neurodegenerative disorders such as Parkinson's disease and Alzheimer's disease. In addition, oxygen radicals are known to be important mediators in acute pathologies, in the theory of senescence, cancer, as well as our healthy immune system. Although free radicals may have a special chemical nature which allows them to perform important cellular functions, they are a damaging entity whose reactivity may play a part in the development of cellular compromises that can kill a neuron. In this review, the free radicals in biological systems, the defense systems against them, and the damaging interactions, i.e., oxidative stress, which they confer are discussed. The descriptions provided raise the hypothesis that an imbalance between the production and removal of radicals would be abrasive on a neuron. Accordingly, the neurodegeneration initially caused by gene mutation in Huntington's disease may be further worsened by free radical damage underlied by oxidative stress. This article reviews existing data on the free radical damage and the oxidative stress, which are primarily directed towards Parkinson's disease and Alzheimer's disease, and whenever possible relates such mechanisms to Huntington's disease.


Assuntos
Doença de Huntington/metabolismo , Estresse Oxidativo , Espécies Reativas de Oxigênio/metabolismo , Doença de Alzheimer/metabolismo , Antioxidantes/metabolismo , Metabolismo Energético , Radicais Livres/metabolismo , Humanos , Doença de Huntington/genética , Mutação/genética , Degeneração Neural , Neurônios/metabolismo , Doença de Parkinson/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...